SUPPLEMENT

Q1 2022 — Supplemental Sales Data

Q1 2022PDF · 2 pages33 KB
Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
2022 2021 Total Operations Currency
Sales to customers by
segment of business
Consumer Health (1)
U.S. 1,557	$ 1,611 (3.4) % (3.4) -
International 2,029 2,030 0.0 4.1 (4.1)
3,586 3,641 (1.5) 0.8 (2.3)
Pharmaceutical (1)
U.S. 6,632 6,446 2.9 2.9 -
International 6,237 5,655 10.3 16.7 (6.4)
12,869 12,101 6.3 9.3 (3.0)
MedTech (2)
U.S. 3,225 3,054 5.6 5.6 -
International 3,746 3,525 6.3 11.1 (4.8)
6,971 6,579 5.9 8.5 (2.6)
U.S. 11,414 11,111 2.7 2.7 -
International 12,012 11,210 7.2 12.6 (5.4)
Worldwide 23,426	$ 22,321 5.0 % 7.7 (2.7)
Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely.
FIRST QUARTER
Percent Change
(1) Certain international OTC products, primarily in China, were reclassified from the Pharmaceutical segment to the Consumer Health segment based on operational
changes in their respective regions
(2) Previously referred to as Medical Devices

-- 1 of 2 --

Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
2022 2021 Total Operations Currency
Sales to customers by
geographic area
U.S. 11,414	$ 11,111 2.7 % 2.7 -
Europe 6,024 5,414 11.3 19.5 (8.2)
Western Hemisphere excluding U.S. 1,482 1,424 4.1 5.1 (1.0)
Asia-Pacific, Africa 4,506 4,372 3.1 6.6 (3.5)
International 12,012 11,210 7.2 12.6 (5.4)
Worldwide 23,426	$ 22,321 5.0 % 7.7 (2.7)
Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely.
FIRST QUARTER
Percent Change

-- 2 of 2 --